FDA contradicts Trump admin, declines to approve generic drug for autism

In the end, the FDA only approved the drug for a rare genetic condition with clearer data.

This news item is fetched from a public RSS feed. Title, summary, and image are © their respective publisher; follow the link above to read the full article on the original site.